NPI registry status
Active
2026 NPPES data Pediatric Hematology & Oncology Physician NPI 1528011269 MD
Verify on CMS → Drew Rosielle, MD
Pediatric Hematology & Oncology Physician in Minneapolis, Minnesota.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 2,568 in Pediatric Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 154 beneficiaries · Pediatric Hematology & Oncology Physician avg: 92
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.7/100
▼ 1 pts below national avg 83.1 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Drew Rosielle, MD reported a CMS MIPS final score of 81.7/100 - below the 83.1 national average - and filed 1,034 Medicare Part D claims in 2023.
- 81.7/100
- MIPS score · -1 vs avg
- 1K
- Part D claims, 2023
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Drew Rosielle, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
82 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Drew Rosielle, MD sits
This provider among pediatric hematology & oncology physician peers
Across the 57 pediatric hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Drew Rosielle, MD writes more Part D claims than 98% of them and scores higher on MIPS quality than 47% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pediatric hematology & oncology physician peer from a representative sample of 56; the gold marker is Drew Rosielle, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Drew Rosielle, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Drew Rosielle, MD?
Near national averagePrimary specialty
Pediatric Hematology & Oncology Physician
Medicare Part D claims
1,034 11× vs specialty avg
MIPS final score
81.7/100 1.4 pts vs avg
Specialty distribution in Minnesota
How Pediatric Hematology & Oncology Physician compares to other specialties among Minnesota providers
Medicare quality performance, MIPS
Drew Rosielle, MD's 2023 MIPS final score plotted against the Pediatric Hematology & Oncology Physician national average
- MIPS Final Score
- 81.7/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pediatric Hematology & Oncology Physician) - 81.7/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Drew Rosielle, MD appears in the CMS NPPES registry as a Pediatric Hematology & Oncology Physician provider holding MD credentials at 420 DELAWARE ST SE, Minneapolis, MN, 55455, with a listed phone of (612) 273-3671. NPI 1528011269 was issued on 05/17/2006.
Medicare Part D records for calendar year 2023 show 1,034 prescription claims written by this provider, covering 154 Medicare beneficiaries and totaling roughly $112K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 43.2%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.7/100 for the 2023 performance year (Quality 69.9, Cost 59.7), compared with the national average of 83.1.
Pediatric Hematology & Oncology Physician is a narrow specialty nationwide, with 2,568 enrolled providers across 52 states and an average of 92 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1528011269 |
|---|---|
| Specialty | Pediatric Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/17/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
81.7216
Final Score
Avg: 83.1
69.8683
Quality
59.7305
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Drew Rosielle, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Fairview Express Care
Saint Paul, MN
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Drew Rosielle, MD - brand share 12.0%
Pediatric Hematology & Oncology Physician average
12% brand-name claims vs 88% generic, on 1,034 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,034
Total Claims
$112K
Total Drug Cost
154
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,167
- Total Day Supply
- 28,588
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $71K
- Generic Drug Cost
- $41K
- Opioid Claims
- 447 (43.2% rate)
Patient Demographics
- Average Patient Age
- 66.9 years
- Avg HCC Risk Score
- 3.19
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 42, 65-74: 75, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Drew Rosielle, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Oxycodone Hcl
Oxycodone Hcl
210 claims
- Gabapentin
Gabapentin
123 claims
- Belbuca 45
Belbuca
45 claims
- Buprenorphine 44
Buprenorphine
44 claims
- Celecoxib 35
Celecoxib
35 claims
- Hydrocodone-Acetam… 35
Hydrocodone-Acetaminophen
35 claims
- Modafinil 33
Modafinil
33 claims
- Duloxetine Hcl 28
Duloxetine Hcl
28 claims
| Drug | Claims |
|---|---|
| Oxycodone Hcl | 210 |
| Gabapentin | 123 |
| Belbuca Buprenorphine Hcl | 45 |
| Buprenorphine | 44 |
| Celecoxib | 35 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 35 |
| Modafinil | 33 |
| Duloxetine Hcl | 28 |
| Pregabalin | 28 |
| Morphine Sulfate Er Morphine Sulfate | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Pediatric Hematology & Oncology Physician in MN →
All providers in Minnesota →
Compare specialties →
Pediatric Hematology & Oncology Physician Overview
How Drew Rosielle, MD fits within the Pediatric Hematology & Oncology Physician landscape nationally.
2,568
Pediatric Hematology & Oncology Physician Providers in US
52
States with Pediatric Hematology & Oncology Physician
92
Avg Claims per Provider
Drew Rosielle, MD's 1,034 claims are above the specialty average of 92.
Nearby Pediatric Hematology & Oncology Physician Providers in Minnesota
Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as Rosielle.
Dr. Ahmad Al-Huniti
M.D
Rochester, MN
Dr. Kelly Bailey
MD, PHD
Rochester, MN
Dr. Anne Bendel
MD
Minneapolis, MN
Dr. Laura Bou-Maroun
MD
Minneapolis, MN
Dr. Alexander Boucher
MD
Minneapolis, MN
Compare Pediatric Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Minnesota medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pediatric Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Minnesota
Frequently Asked Questions
What is Drew Rosielle, MD's specialty? ▼
Drew Rosielle, MD specializes in Pediatric Hematology & Oncology Physician and practices in Minneapolis, Minnesota. Credentials: MD.
How much does Drew Rosielle, MD prescribe under Medicare Part D? ▼
In 2023, Drew Rosielle, MD wrote 1,034 Medicare Part D claims totaling $112K in drug costs for 154 beneficiaries.
What is Drew Rosielle, MD's Medicare quality score? ▼
Drew Rosielle, MD has a CMS MIPS Final Score of 81.7/100 (Quality: 69.9, Cost: 59.7). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Drew Rosielle, MD located? ▼
Drew Rosielle, MD is located at 420 DELAWARE ST SE, Minneapolis, MN, 55455. Phone: (612) 273-3671.
What is Drew Rosielle, MD's NPI number? ▼
Drew Rosielle, MD's National Provider Identifier (NPI) is 1528011269, issued on 05/17/2006.
Does Drew Rosielle, MD prescribe more brand-name or generic drugs? ▼
Drew Rosielle, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $71K in brand drug costs.
Does Drew Rosielle, MD prescribe opioids? ▼
Yes, Drew Rosielle, MD had 447 opioid claims in 2023 with an opioid prescribing rate of 43.2%.
How many Pediatric Hematology & Oncology Physician providers are there in the US? ▼
There are 2,568 Pediatric Hematology & Oncology Physician providers across 52 states in the US. The average Pediatric Hematology & Oncology Physician provider writes 92 Medicare Part D claims per year.
What drugs does Drew Rosielle, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Drew Rosielle, MD's most frequently prescribed drugs include Oxycodone Hcl, Gabapentin, Belbuca. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Drew Rosielle, MD accept Medicare? ▼
Drew Rosielle, MD appears in CMS Medicare data with 1,034 Part D claims and 154 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Drew Rosielle, MD's credentials? ▼
Drew Rosielle, MD's NPI is 1528011269 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.